
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency
Nathan M. Markarian, Gaël Galli, Dhanesh Patel, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8
Nathan M. Markarian, Gaël Galli, Dhanesh Patel, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 8
Showing 8 citing articles:
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24
Plasmonic digital PCR for discriminative detection of SARS-CoV-2 variants
Kyung Ho Kim, Eunsu Ryu, Zinah Hilal Khaleel, et al.
Biosensors and Bioelectronics (2023) Vol. 246, pp. 115859-115859
Closed Access | Times Cited: 7
Kyung Ho Kim, Eunsu Ryu, Zinah Hilal Khaleel, et al.
Biosensors and Bioelectronics (2023) Vol. 246, pp. 115859-115859
Closed Access | Times Cited: 7
Systems analysis of human innate immunity in COVID-19
Sophie Merit Müller, Joachim L. Schultze
Seminars in Immunology (2023) Vol. 68, pp. 101778-101778
Open Access | Times Cited: 6
Sophie Merit Müller, Joachim L. Schultze
Seminars in Immunology (2023) Vol. 68, pp. 101778-101778
Open Access | Times Cited: 6
Identification of natural compounds as SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation
Tiantian Han, Ziqing Luo, Lichun Ji, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Tiantian Han, Ziqing Luo, Lichun Ji, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes
Ted Ling-Hu, Lacy M. Simons, Taylor J. Dean, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101361-101361
Open Access | Times Cited: 1
Ted Ling-Hu, Lacy M. Simons, Taylor J. Dean, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101361-101361
Open Access | Times Cited: 1
Editorial: Immune determinants of COVID-19 protection and disease: A focus on asymptomatic COVID and long COVID
Maria J. Polyak, Levon Abrahamyan, Mariana G. Bego
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Maria J. Polyak, Levon Abrahamyan, Mariana G. Bego
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Genomic Surveillance of SARS-CoV-2 Variants at a Reference Cancer Hospital in Rio de Janeiro, Brazil
Élida Mendes de Oliveira, Caroline Carvalho de Sá, Julia Botto de Barros Cordeiro, et al.
Revista Brasileira de Cancerologia (2024) Vol. 70, Iss. 3
Open Access
Élida Mendes de Oliveira, Caroline Carvalho de Sá, Julia Botto de Barros Cordeiro, et al.
Revista Brasileira de Cancerologia (2024) Vol. 70, Iss. 3
Open Access
Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains
Maximillian Woodall, Samuel Ellis, Shengyuan Zhang, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Maximillian Woodall, Samuel Ellis, Shengyuan Zhang, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access